<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Olajumoke Evangelina Owokotomo</title>
    <link>https://OlajumokeEvangelina.github.io/authors/admin/</link>
    <description>Recent content on Olajumoke Evangelina Owokotomo</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 03 Sep 2018 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="https://OlajumokeEvangelina.github.io/authors/admin/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer</title>
      <link>https://OlajumokeEvangelina.github.io/publication/journal-article/</link>
      <pubDate>Mon, 03 Sep 2018 00:00:00 +0000</pubDate>
      
      <guid>https://OlajumokeEvangelina.github.io/publication/journal-article/</guid>
      <description></description>
    </item>
    
    <item>
      <title></title>
      <link>https://OlajumokeEvangelina.github.io/authors/admin/</link>
      <pubDate>Mon, 03 Sep 2018 00:00:00 +0000</pubDate>
      
      <guid>https://OlajumokeEvangelina.github.io/authors/admin/</guid>
      <description>&lt;p&gt;Olajumoke Evangelina Owokotomo is a doctoral researcher at the Intervisity institute of biostatistics and statistical bioinformatics, universiteit Hasselt, Belgium. Her research focuses on the developement of biomarker for high-dimensional omics data such as microbiome data, metabolic data, gene expression data, etc.&lt;/p&gt;

&lt;p&gt;Currently she is working on developing a new measure of surrogacy that can be applied to various endpoint using the Bayesian variable approach . The measure is a probability measure that tells the probability of how important is the biomarker is for the endpoint of interest.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
